TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,192 | 859 | 181 |
Financial expenses | 22 | 15 | 0 |
Earnings before taxes | 91 | 140 | -63 |
EBITDA | 70 | 163 | -63 |
Total assets | 353 | 289 | 81 |
Current assets | 270 | 199 | 51 |
Current liabilities | 348 | 238 | 92 |
Equity capital | 5 | 51 | -97 |
- share capital | 34 | 33 | 36 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 1.4% | 17.6% | -119.8% |
Turnover per employee | 596 | 430 | 90 |
Profit as a percentage of turnover | 7.6% | 16.3% | -34.8% |
Return on assets (ROA) | 32.0% | 53.6% | -77.8% |
Current ratio | 77.6% | 83.6% | 55.4% |
Return on equity (ROE) | 1820.0% | 274.5% | 64.9% |
Change turnover | 328 | 692 | -154 |
Change turnover % | 38% | 416% | -46% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.